Department of Internal Medicine, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tübingen, Baden-wurttemberg, Germany.
Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Baden-wurttemberg, Germany.
Curr Med Chem. 2022;29(42):6433-6445. doi: 10.2174/0929867329666220608162256.
Experimental nephrotic syndrome in mice leads to proteolytic activation of the epithelial sodium channel ENaC, possibly involving the distal polybasic tract of its γ-subunit (183RKRK).
We sought to determine if urine samples from both nephrotic mice and a cohort of patients with acute nephrotic syndrome contain a specific proteolytic activity against this region of γ-ENaC.
A peptide substrate consisting of amino acids 180-194 of murine γ-ENaC was N-terminally coupled to a fluorophore, yielding AMCA-FTGRKRKISGKIIHK. The substrate was incubated with nephrotic urine samples from mice as well as patients with or without the serine protease inhibitor, aprotinin. The digested peptides were separated on a reverse phase HPLC and detected with a fluorescence detector (350/450 nm). Peptide masses of the peaks were determined with a MALDI-TOF mass spectrometer. In addition, urinary proteolytic activity was quantitated using AMC-coupled substrates reflecting different cleavage sites within the polybasic tract.
No significant proteolytic activity against the substrate was found in the urine of healthy humans or mice. Incubation with urine samples of nephrotic patients (n = 8) or mice subjected to three different models of experimental nephrotic syndrome (n = 4 each) led to cleavage of the substrate within the polybasic tract prevented by the serine protease inhibitor aprotinin. The most dominant cleavage product was FTGRKR in both species, which was confirmed using quantitative measurements with FTGRKR- AMC.
Nephrotic urine from both humans and mice contains aprotinin-sensitive proteolytic activity against the distal polybasic tract of γ-ENaC, reflecting excretion of active proteases in the urine or proteasuria.
实验性小鼠肾病综合征会导致上皮钠通道 ENaC 的蛋白水解激活,这可能涉及到其γ亚基(183RKRK)的远端多碱性区域。
我们试图确定肾病小鼠和一组急性肾病综合征患者的尿液样本中是否含有针对 γ-ENaC 该区域的特定蛋白水解活性。
用荧光团将包含小鼠 γ-ENaC 的 180-194 个氨基酸的肽底物 N 端偶联,得到 AMCA-FTGRKRKISGKIIHK。将底物与肾病小鼠以及有或没有丝氨酸蛋白酶抑制剂抑肽酶的患者的肾病尿液样本一起孵育。用反相 HPLC 分离消化的肽,并使用荧光检测器(350/450nm)检测。用 MALDI-TOF 质谱仪测定峰的肽质量。此外,还使用反映多碱性区域内不同切割位点的 AMCA 偶联底物定量测定尿蛋白水解活性。
在健康人和小鼠的尿液中未发现对该底物有明显的蛋白水解活性。与肾病患者的尿液样本(n=8)或接受三种不同实验性肾病综合征模型的小鼠尿液样本(n=4)孵育会导致丝氨酸蛋白酶抑制剂抑肽酶抑制的多碱性区域内的底物裂解。在这两种物种中,最主要的裂解产物都是 FTGRKR,这一点通过使用 FTGRKR-AMCA 进行定量测量得到了证实。
人和小鼠的肾病尿液都含有针对 γ-ENaC 远端多碱性区域的抑肽酶敏感蛋白水解活性,反映了尿液中活性蛋白酶的排泄或蛋白酶尿。